|
Market Cap (3-Jul) $43,777,552 (0th) |
Close (30-Jun) $0.300 |
Volume (30-Jun) 160,000 |
Shortsold (19-Jun) 3,649,691 (0.81%) (242nd) |
|
52w High $0.325 |
52w Low $0.082 |
P/E - |
EPS -0.03 |
MAP released this announcement to the ASX on 29 March 2023, 14:39. The announcement is marked as price sensitive, and is 2 page(s) in length and 170.02kb in size.
You can view all announcements from MAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, MAP was 0.001% short sold according to ASIC data. It was ranked the 630th most shorted stock on the ASX. It is now ranked as the 242nd most shorted stock on the ASX with 0.815% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MAP | |
|---|---|
| Notification of cessation of securities - MAP | 30 June 2023, 17:06 |
| Microba Commences Phase I Clinical Trial for IBD Therapeutic | 28 June 2023, 9:04 |
| MRFF Grant Awarded to QUT, In Collaboration With Microba | 27 June 2023, 11:17 |
| Microba Receives Ethics Approval for Phase 1 Clinical Trial | 29 March 2023, 14:39 |
| Release of Securities from Voluntary Escrow | 28 March 2023, 9:05 |
| NWR Virtual Healthcare Conference Presentation | 21 March 2023, 9:46 |
| Microba to present at NWR Virtual Investor Conference | 16 March 2023, 9:07 |
You must be logged in to post a reply.
